ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Steven R. Gundry
Arnold G. Coran
John Lemmer
John R. Wesley
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gundry, S. R.
Right arrow Articles by Hutchinson, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gundry, S. R.
Right arrow Articles by Hutchinson, R.

Ann Thorac Surg 1984;38:473-478
© 1984 The Society of Thoracic Surgeons


Articles

The Influence of Tumor Microfoci on Recurrence and Survival Following Pulmonary Resection of Metastatic Osteogenic Sarcoma

Steven R. Gundry, M.D., Arnold G. Coran, M.D.1, John Lemmer, M.D., John R. Wesley, M.D., Raymond Hutchinson, M.D.

Section of Pediatric Surgery and Department of Pediatrics, Mott Children's Hospital, University of Michigan Medical Center, Ann Arbor, MI.

1 Address reprint requests to Dr. Coran, F7516 Mott Children's Hospital, Box 66, Ann Arbor, MI 48109.

Factors that influence recurrence and survival following thoracotomy for metastatic osteogenic sarcoma are not well defined. We examined the clinical and pathological material from 51 patients who had no metastases at the time of operative treatment of osteogenic sarcoma at the University of Michigan from 1962 to 1982. Ages ranged from 2 to 30 years (mean, 15 years). Metastases developed in 37 patients (72.5%) at a mean of 8 months after initial operation. Thirteen patients were treated with chemotherapy only; 12 of them died after a mean survival of 7 months. Twenty-four patients were treated with chemotherapy and 45 thoracotomies (mean, 1.9 per patient-range, 1 to 5) during which 120 wedge resections or lobectomies were performed. Follow-up is available on 22 of these 24 patients, 11 (50%) of whom are alive (9, tumor free) at a mean of 51 months after thoracotomy. Eleven patients died after a mean survival of 27 months p ≤ 0.001 compared with the group having chemotherapy only).

Microfoci of tumor (tumor cells separate from the gross tumor nodule) were found in resection specimens in 12 patients at the first thoracotomy; in 11 of these 12 patients, new metastases subsequently developed resulting in 10 reoperations. Twelve patients had no microfoci at the first operation; new metastases developed in 5; 3 underwent reoperation. Overall, microfoci were found at 29 operations; in patients with this finding, new metastases developed twenty-seven times (93%). New metastases developed in patients with microfoci at a mean of 5 months versus a 12-month recurrence rate in patients without this finding (p ≤ 0.01). Six (67%) of 9 tumor-free survivors were without microfoci at operation, whereas 9 (82%) of the 11 patients who died had microfoci found at 1 or more operations.

We conclude that the presence of micrometastases in the specimen obtained at pulmonary resection predicts a high rate of early and frequent recurrence of pulmonary metastases and low survival. Patients with this finding require more frequent follow-up and aggressive therapy. Despite the high rate of recurrence, aggressive pulmonary resection substantially prolongs survival compared with patients treated without operation. Therefore, the presence of microfoci should not preclude subsequent chemotherapy or surgical therapy.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. Shiono, G. Ishii, A. Ochiai, and K. Nagai
Reply
Ann. Thorac. Surg., April 1, 2006; 81(4): 1548 - 1548.
[Full Text] [PDF]


Home page
JCOHome page
H. Tsuchiya, Y. Kanazawa, M. E. Abdel-Wanis, N. Asada, S. Abe, K. Isu, T. Sugita, and K. Tomita
Effect of Timing of Pulmonary Metastases Identification on Prognosis of Patients With Osteosarcoma: The Japanese Musculoskeletal Oncology Group Study
J. Clin. Oncol., August 15, 2002; 20(16): 3470 - 3477.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
R. J. Landreneau, T. De Giacomo, M. J. Mack, S. R. Hazelrigg, P. F. Ferson, R. J. Keenan, J. D. Luketich, A. P. Yim, and G. F. Coloni
Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases
Eur J Cardiothorac Surg, December 1, 2000; 18(6): 671 - 677.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1984 by The Society of Thoracic Surgeons.